FDA Rejects Epidermolysis Bullosa Cell Therapy and Requests Additional Manufacturing Data
source: shutterstock.com

FDA Rejects Epidermolysis Bullosa Cell Therapy and Requests Additional Manufacturing Data

Clinical-stage biotechnology company Abeona Therapeutics ("Abeona") is working to develop a novel cell therapy for people living with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic skin disorder characterized by…

Continue Reading FDA Rejects Epidermolysis Bullosa Cell Therapy and Requests Additional Manufacturing Data
Vyjuvek for DEB Earns Orphan Drug Designation in Japan
source: pixabay.com

Vyjuvek for DEB Earns Orphan Drug Designation in Japan

Healio Psoriatic Disease recently reported that Vyjuvek (beremagene geperpavec-svdt), a topical gene therapy designed for people with dystrophic epidermolysis bullosa (DEB), was granted Orphan Drug designation (ODD) by the Japanese…

Continue Reading Vyjuvek for DEB Earns Orphan Drug Designation in Japan
Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa
source: unsplash.com

Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa

According to a story from VICE News, Congressman George Santos was recently elected to Congress in the 2022 mid-term elections. Since then, his past has been placed under scrutiny, and…

Continue Reading Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa

Raising Awareness of Recessive Dystrophic Epidermolysis Bullosa: Patterson’s Story (Pt. 2)

Before you read on, make sure to check out Part 1 of our interview, where Annie, Peter, and Patterson discuss what recessive dystrophic epidermolysis bullosa (RDEB) is, Patterson's diagnostic journey, and how…

Continue Reading Raising Awareness of Recessive Dystrophic Epidermolysis Bullosa: Patterson’s Story (Pt. 2)
Study Shares Calcipotriol Benefits for Dystrophic Epidermolysis Bullosa
jniittymaa0 / Pixabay

Study Shares Calcipotriol Benefits for Dystrophic Epidermolysis Bullosa

People with epidermolysis bullosa (EB) often experience symptoms such as intense itching or severe pain. Unfortunately, these symptoms can be debilitating and may greatly affect overall quality-of-life. However, some burgeoning…

Continue Reading Study Shares Calcipotriol Benefits for Dystrophic Epidermolysis Bullosa

Two Epidermolysis Bullosa Nonprofits United to Make the Largest Global Organization for EB

EB Research Partnership (EBRP) is based out of New York, United States. EB Research Foundation (EBRF) is an organization based out of Australia with the same goals. The two organizations  have…

Continue Reading Two Epidermolysis Bullosa Nonprofits United to Make the Largest Global Organization for EB